Table 1.
Characteristics of the study cohort.
| Unexposed (n = 66) | Prior SARS-CoV-2 infection (n = 8) | SARS-CoV-2 infection after dose 1 (n = 4) | SARS-CoV-2 infection after dose 2 (n = 4) | |
|---|---|---|---|---|
| General characteristics | ||||
| Age (years) | 43 (26−80) | 44 (33−51) | 39 (26−48) | 44 (29−51) |
| Sex, n (%) | 50/16 (76/24) | 3/5 (38/62) | 4/0 (100/0) | 4/0 (100/0) |
| Female/Male | ||||
| SARS-CoV-2-related characteristics | ||||
| Mild cases, n | 0 | 8 | 4 | 4 |
| Time since infection to dose 1 (months) | NA | 6.5 (4−8) | NA | NA |
| SARS-CoV-2 infection after dose 1 (days) | NA | NA | 49 (37−49) | NA |
| SARS-CoV-2 infection after dose 2 (days) | NA | NA | NA | 12.5 (5−96) |
Values are expressed as median (range) or n (%). NA not applicable.